New Products: Titan Spine Earns 510(k) For Lateral Fusion Device; Data On Misonix’ Ultrasonic BoneScalpel Published; Boston Scientific Earns CE Mark For Midsized TAVR
This article was originally published in The Gray Sheet
Executive Summary
Titan boasts its Endoskeleton TL is the first lateral spine fusion device to feature surface technology. New trial data shows surgical correction of adolescent idiopathic scoliosis with the ultrasonic BoneScalpel reduces blood-loss. Boston Scientific set to launch 25 mm version of Lotus transcatheter aortic valve in Europe to compliment 23 mm and 27 mm sizes.
You may also be interested in...
TAVR Evolution On Display At EuroPCR
Data on both new transcatheter aortic valve technologies and established TAVR devices were featured at this year’s EuroPCR meeting in Paris.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.